chloroquine has been researched along with epigallocatechin gallate in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Brun, R; Carballeira, NM; Herman, R; Kappe, SH; Lauinger, IL; Perozzo, R; Sanabria, D; Tarun, A; Tasdemir, D; Zloh, M | 1 |
| Belluti, F; Bisi, A; Bolognesi, ML; Brun, R; Cavalli, A; Colizzi, F; Gobbi, S; Kostrewa, D; Lauciello, L; Perozzo, R; Rampa, A; Recanatini, M; Scapozza, L | 1 |
| Andricopulo, AD; Bwalya, AG; Carballeira, NM; Cordero-Maldonado, ML; Crawford, AD; Guido, RV; Itoe, MA; Kaiser, M; Mota, MM; Tasdemir, D | 1 |
| Akoto, M; Avery, VM; Duffy, S; Hagen, TJ; Helgren, TR; Igbinoba, O; Lee, P; Sciotti, RJ | 1 |
| Bernatchez, JA; Li, J; Li, R; Luan, Y; Siqueira-Neto, JL; Tran, LT | 1 |
| Chen, J; Chen, W; Choudhry, N; Xu, D; Yang, Z; Zanin, M; Zhao, X | 1 |
| Gu, HF; Jing, KQ; Liao, DF; Nie, YX; Tang, YL; Tong, QZ; Zeng, Y; Zheng, XL | 1 |
2 review(s) available for chloroquine and epigallocatechin gallate
| Article | Year |
|---|---|
Drugs for the Treatment of Zika Virus Infection.
Topics: Animals; Antiviral Agents; Drug Development; Drug Discovery; Humans; Viral Vaccines; Zika Virus; Zika Virus Infection | 2020 |
Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Topics: Antiviral Agents; China; Coronavirus Protease Inhibitors; COVID-19; COVID-19 Drug Treatment; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; SARS-CoV-2; Small Molecule Libraries | 2020 |
5 other study(ies) available for chloroquine and epigallocatechin gallate
| Article | Year |
|---|---|
2-Hexadecynoic acid inhibits plasmodial FAS-II enzymes and arrests erythrocytic and liver stage Plasmodium infections.
Topics: Alkynes; Antimalarials; Binding Sites; Cell Line, Tumor; Computer Simulation; Erythrocytes; Fatty Acid Synthase, Type II; Fatty Acids, Unsaturated; Humans; Kinetics; Liver; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins | 2010 |
Design, synthesis, and biological and crystallographic evaluation of novel inhibitors of Plasmodium falciparum enoyl-ACP-reductase (PfFabI).
Topics: Animals; Antimalarials; Cell Line; Coumarins; Crystallography, X-Ray; Drug Design; Drug Resistance, Multiple; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Molecular Docking Simulation; Plasmodium falciparum; Protein Binding; Protein Conformation; Structure-Activity Relationship | 2013 |
2-Octadecynoic acid as a dual life stage inhibitor of Plasmodium infections and plasmodial FAS-II enzymes.
Topics: Animals; Antimalarials; Cell Line, Tumor; Dose-Response Relationship, Drug; Fatty Acid Synthase, Type II; Fatty Acids, Unsaturated; Humans; Malaria; Models, Molecular; Plasmodium berghei; Plasmodium falciparum; Structure-Activity Relationship; Zebrafish | 2014 |
The synthesis, antimalarial activity and CoMFA analysis of novel aminoalkylated quercetin analogs.
Topics: Antimalarials; Humans; Malaria; Models, Molecular; Molecular Structure; Plasmodium falciparum; Quantitative Structure-Activity Relationship; Quercetin; Stereoisomerism | 2015 |
Epigallocatechin-3-gallate attenuates impairment of learning and memory in chronic unpredictable mild stress-treated rats by restoring hippocampal autophagic flux.
Topics: Amyloid beta-Peptides; Animals; Autoantigens; Autophagy; CA1 Region, Hippocampal; Catechin; Chloroquine; Chronic Disease; Cognitive Dysfunction; Gene Expression Regulation; Male; Maze Learning; Memory; Microtubule-Associated Proteins; Neurons; Nootropic Agents; Peptide Fragments; Rats; Rats, Wistar; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Stress, Psychological; TOR Serine-Threonine Kinases | 2014 |